文献速递呼吸道感染呼吸危重症与机械通气

COVID-19重症患者谵妄患病率及危险因素:多中心队列研究

Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.
PubMed 文献 · Lancet Respir Med · 2021-01-08

机械通气、约束、苯二氮䓬类、阿片类、血管升压药及抗精神病药与次日谵妄风险升高相关,家属探视与风险降低相关。

要点

  • COVID-19重症患者急性脑功能障碍高发且持续时间长。
  • 苯二氮䓬类使用和缺乏家属探视是可干预的谵妄危险因素。
  • 机械通气、约束、阿片类、血管升压药及抗精神病药与次日谵妄风险升高相关。

核心结论

  • COVID-19重症患者急性脑功能障碍(昏迷和谵妄)非常普遍且持续时间长。
  • 苯二氮䓬类使用和缺乏家属探视是可干预的谵妄危险因素,提示有机会减少急性脑功能障碍。

研究设计与样本

  • 多中心队列研究,纳入14个国家69个成人ICU。
  • 纳入2020年4月28日前入住参与ICU的≥18岁SARS-CoV-2感染患者,共2088例。
  • 排除入ICU 24小时内濒死或撤除生命支持、囚犯、既存精神疾病、神经退行性疾病、先天或获得性脑损伤、肝性昏迷、药物过量、自杀未遂、盲或聋的患者。
  • 收集21天电子健康记录数据(人口学、谵妄和昏迷评估、管理策略),并收集28天呼吸机支持、ICU住院时长和生命状态数据。
  • 主要结局为谵妄和昏迷的患病率及次日谵妄相关危险因素,采用多变量回归分析。

主要发现

  • 有创机械通气期间中位RASS评分为-4(IQR -5至-3)。

临床怎么用

  • 对COVID-19重症患者应常规评估谵妄和昏迷。
  • 考虑减少苯二氮䓬类使用,并促进家属探视(亲自或虚拟)以降低谵妄风险。
  • 关注机械通气、约束、阿片类、血管升压药及抗精神病药等可干预因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To date, 750 000 patients with COVID-19 worldwide have required mechanical ventilation and thus are at high risk of acute brain dysfunction (coma and delirium). We aimed to investigate the prevalence of delirium and coma, and risk factors for delirium in critically ill patients with COVID-19, to aid the development of strategies to mitigate delirium and associated sequelae. METHODS: This multicentre cohort study included 69 adult intensive care units (ICUs), across 14 countries. We included all patients (aged ≥18 years) admitted to participating ICUs with severe acute respiratory syndrome coronavirus 2 infection before April 28, 2020. Patients who were moribund or had life-support measures withdrawn within 24 h of ICU admission, prisoners, patients with pre-existing mental illness, neurodegenerative disorders, congenital or acquired brain damage, hepatic coma, drug overdose, suicide attempt, or those who were blind or deaf were excluded. We collected de-identified data from electronic health records on patient demographics, delirium and coma assessments, and management strategies for a 21-day period. Additional data on ventilator support, ICU length of stay, and vital status was collected for a 28-day period. The primary outcome was to determine the prevalence of delirium and coma and to investigate any associated risk factors associated with development of delirium the next day. We also investigated predictors of number of days alive without delirium or coma. These outcomes were investigated using multivariable regression. FINDINGS: Between Jan 20 and April 28, 2020, 4530 patients with COVID-19 were admitted to 69 ICUs, of whom 2088 patients were included in the study cohort. The median age of patients was 64 years (IQR 54 to 71) with a median Simplified Acute Physiology Score (SAPS) II of 40·0 (30·0 to 53·0). 1397 (66·9%) of 2088 patients were invasively mechanically ventilated on the day of ICU admission and 1827 (87·5%) were invasively mechanical ventilated at some point during hospitalisation. Infusion with sedatives while on mechanical ventilation was common: 1337 (64·0%) of 2088 patients were given benzodiazepines for a median of 7·0 days (4·0 to 12·0) and 1481 (70·9%) were given propofol for a median of 7·0 days (4·0 to 11·0). Median Richmond Agitation-Sedation Scale score while on invasive mechanical ventilation was -4 (-5 to -3). 1704 (81·6%) of 2088 patients were comatose for a median of 10·0 days (6·0 to 15·0) and 1147 (54·9%) were delirious for a median of 3·0 days (2·0 to 6·0). Mechanical ventilation, use of restraints, and benzodiazepine, opioid, and vasopressor infusions, and antipsychotics were each associated with a higher risk of delirium the next day (all p≤0·04), whereas family visitation (in person or virtual) was associated with a lower risk of delirium (p<0·0001). During the 21-day study period, patients were alive without delirium or coma for a median of 5·0 days (0·0 to 14·0). At baseline, older age, higher SAPS II scores, male sex, smoking or alcohol abuse, use of vasopressors on day 1, and invasive mechanical ventilation on day 1 were independently associated with fewer days alive and free of delirium and coma (all p<0·01). 601 (28·8%) of 2088 patients died within 28 days of admission, with most of those deaths occurring in the ICU. INTERPRETATION: Acute brain dysfunction was highly prevalent and prolonged in critically ill patients with COVID-19. Benzodiazepine use and lack of family visitation were identified as modifiable risk factors for delirium, and thus these data present an opportunity to reduce acute brain dysfunction in patients with COVID-19. FUNDING: None. TRANSLATIONS: For the French and Spanish translations of the abstract see Supplementary Materials section.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Pun BT, Badenes R, Heras La Calle G, et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021. PMID: 33428871. doi:10.1016/S2213-2600(20)30552-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。